Epstein-Barr virus receptors on human pharyngeal epithelia
- PMID: 2868257
- DOI: 10.1016/s0140-6736(86)90776-2
Epstein-Barr virus receptors on human pharyngeal epithelia
Abstract
The apparently strict tropism of Epstein-Barr virus (EBV) for B lymphocytes has been attributed to the existence of a B-lineage-specific surface molecule, the C3d receptor, which also functions as a receptor for EBV. Two monoclonal antibodies against different determinants on the EBV/C3d receptor of B cells were shown to react with pharyngeal epithelia in a cell differentiation-dependent manner. These findings, which raise the possibility of direct virus entry into a naturally exposed epithelium, strengthen the evidence in favour of an epithelial reservoir of EBV infection in vivo and identify a means whereby the virus/epithelium interactions leading to nasopharyngeal carcinoma might be initiated.
Similar articles
-
Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.Reg Immunol. 1990-1991;3(4):164-70. Reg Immunol. 1990. PMID: 1966579
-
Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).J Virol. 1985 Aug;55(2):347-51. doi: 10.1128/JVI.55.2.347-351.1985. J Virol. 1985. PMID: 2410629 Free PMC article.
-
The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.Acta Virol. 1989 Aug;33(4):375-7. Acta Virol. 1989. PMID: 2574946
-
Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.Annu Rev Immunol. 1988;6:85-113. doi: 10.1146/annurev.iy.06.040188.000505. Annu Rev Immunol. 1988. PMID: 2838050 Review. No abstract available.
-
Expression of EBV/C3d receptors on T cells: biological significance.Immunol Today. 1993 Feb;14(2):56-9. doi: 10.1016/0167-5699(93)90059-T. Immunol Today. 1993. PMID: 8383497 Review.
Cited by
-
Epstein-Barr virus infection in cultured non-malignant epithelial cells from human nasopharyngeal mucosa.Arch Otorhinolaryngol. 1989;246(3):142-6. doi: 10.1007/BF00456655. Arch Otorhinolaryngol. 1989. PMID: 2547353
-
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.J Virol. 1990 Sep;64(9):4084-92. doi: 10.1128/JVI.64.9.4084-4092.1990. J Virol. 1990. PMID: 2166806 Free PMC article.
-
Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV.J Virol. 1987 Dec;61(12):3774-82. doi: 10.1128/JVI.61.12.3774-3782.1987. J Virol. 1987. PMID: 2446007 Free PMC article.
-
Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma in Northern Ireland.Ir J Med Sci. 1987 Jun;156(6):182-4. doi: 10.1007/BF02955201. Ir J Med Sci. 1987. PMID: 3040619 No abstract available.
-
Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.Springer Semin Immunopathol. 1991;13(2):117-31. doi: 10.1007/BF00201463. Springer Semin Immunopathol. 1991. PMID: 1664981 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources